DIMERIX LTD

Investors Eye Dimerix’s AGM: 2026 Meeting Sparks Governance Boost & Capital‑Raising Move

Explore Dimerix Limited’s latest stock update and AGM agenda—key financial insights, board changes, and a 10% placement capacity boost for investors.

Jake Connors

23/10/2026, 23:26

3 minutes to read

Track Dimerix Limited: Latest Stock Move, AGM Highlights, and 24‑Hour Market Insight

Get the latest Dimerix Limited trading data, AGM agenda, and biotech focus on kidney disease therapies—stock performance, market cap, and governance updates.

Elliot Mercer

22/10/2026, 23:27

2 minutes to read

Analyze Dimerix (DXB.AX) Stock: Current Price, Market Cap, & Recent Performance

Track Dimerix (DXB.AX) stock: AUD 0.21, 24‑hour drop, 12‑month trend, biotech focus on kidney disease therapies.

Elliot Mercer

21/10/2026, 14:39

One minute to read

Watch Dimerix Limited Slide 4.6% to AUD 0.20—Below 200‑Day MA on ASX

Check Dimerix Limited’s latest market move, 4.55% drop below its 200‑day MA, and how it stacks against peers like West Wits Mining and Vita Life Sciences.